Hua Wu

6PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersBiologically active moleculesCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 10, 2024
TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancer.

Wen-Long Ye, Long Huang, Xiao-Qin Yang

|Apr 22, 2022
Pharmacological Activities of Natural Products through the TGF-β Signalling Pathway.

Chunpeng Craig Wan, Muhammad Farrukh Nisar, Hua Wu

|Jan 21, 2022
Oncogenic potential of BEST4 in colorectal cancer via activation of PI3K/Akt signaling.

Xiao-Shun He, Wen-Long Ye, Yu-Juan Zhang

|Jan 05, 2022
TRIP6 promotes inflammatory damage via the activation of TRAF6 signaling in a murine model of DSS-induced colitis.

Yun Yang, Xiu-Ming Li, Jing-Ru Wang

Pageof 1